Limited coverage drugs – cyproterone
Special Authority requests can now be submitted online. It's simple and quick!
Learn more or log in.
Generic name | Strength | Form |
---|---|---|
cyproterone |
100 mg/1 mL | ampoule |
cyproterone |
50 mg | tablet |
Special Authority criteria |
Approval period |
---|---|
Indication of need to reduce aggressive sexual drive |
Indefinite |
Practitioner exemptions
- None
Special notes
- Criteria applicable for all plans including Plan G
- For any cancer related condition, please contact the British Columbia Cancer Agency at 604-877-6098 Ext. 4610